Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Shore Capital praises AB Foods' actions to turn business around

(Sharecast News) - Shore Capital has reiterated a 'buy' rating for retail and food conglomerate Associated British Foods, praising the company's recent actions to deal with underperforming parts of the business. Ahead of a trading update expected from the firm in September, the broker noted ABF's "demonstrable action to deal with persistent problem children" - namely its bioethanol business Vivergo, the Spanish sugar division Azucarera and UK bakery operations Allied.

The company has already announced that has kickstarted a restructuring of Azucarera, which involves simplifying its manufacturing operations, cutting costs and improving efficiency. Meanwhile, it is currently negotiating with the UK government about Vivergo to find a regulatory solution that it hopes will mitigate certain rules on imported ethanol and the impact of US trade tariffs.

Meanwhile, ABF announced on Friday that it was acquiring the Hovis Brand in an effort to bolster the Allied division, bringing together "two of the leading names in the UK sliced bread market", according to Shore Capital.

"Quite how much profitability will emerge and when, remains to be seen, but we can foresee a welcome boost to ABF's Grocery division here, given that Allied has been making trading losses amounting to, we suspect, £20-30m per annum for some time," the broker said.

Shore Capital said it "applauded these workstreams", adding: "Aligning the stars of ABF is virtuous to the group's investment thesis, to us, and so bringing Allied, Azucarera and Vivergo in from the cold is welcome news.

"In the big scheme of things, [...] we welcome the important improvement in prospects for its UK bakery division, and we reiterate our Buy stance on ABF equity where valuation multiples remain undemanding, to us."

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.